Suppr超能文献

用于内脏动脉损伤的支架移植物置入术

Stent Graft Placement for Injured Visceral Artery.

作者信息

Miyayama Shiro, Yamashiro Masashi, Ikeda Rie, Yokka Akira, Komiya Hideaki, Sakuragawa Naoko, Terada Takuro, Yamamoto Hidekazu

机构信息

Department of Diagnostic Radiology, Fukui-ken Saiseikai Hospital, Japan.

Department of Hepatobiliary-Pancreatic Surgery, Fukui-ken Saiseikai Hospital, Japan.

出版信息

Interv Radiol (Higashimatsuyama). 2023 Nov 1;8(3):173-183. doi: 10.22575/interventionalradiology.2023-0005.

Abstract

Injury of the visceral artery is a potentially fatal complication of iatrogenic procedures, trauma, and tumors. A stent graft can achieve rapid exclusion of the injured arterial portion and minimize the risk of ischemic complications by preserving arterial flow to organs. Although various types of stent grafts are available worldwide, Viabahn has only been approved for visceral arterial injury in Japan. The reported technical and clinical success rates, including cases with injured pelvic or thoracic arterial branches, are 80%-100% and 66.7%-100%, respectively. Severe ischemic complications are rare; however, fatal ischemia occurs when the stent graft is immediately occluded. The necessity of antiplatelet therapy is controversial, and a target artery diameter ≤ 4 mm is a significantly higher risk factor of stent-graft occlusion.

摘要

内脏动脉损伤是医源性操作、创伤和肿瘤潜在的致命并发症。覆膜支架可快速封闭受损动脉段,并通过维持器官动脉血流将缺血并发症风险降至最低。尽管全球有多种类型的覆膜支架,但Viabahn仅在日本被批准用于内脏动脉损伤。报道的技术成功率和临床成功率,包括盆腔或胸段动脉分支损伤病例,分别为80%-100%和66.7%-100%。严重缺血并发症罕见;然而,覆膜支架立即闭塞时会发生致命性缺血。抗血小板治疗的必要性存在争议,且靶动脉直径≤4 mm是覆膜支架闭塞的显著高危因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4135/10681761/6d85631c1d56/2432-0935-8-3-0173-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验